
|Videos|September 24, 2015
The Specialty Pharmacy Patient Experience
Author(s)Davy James, Managing Editor
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses changes ahead for specialty pharmacy patients.
Advertisement
National Association of Specialty Pharmacy (NASP) Executive Director James E. Smeeding, RPh, MBA, discusses changes ahead for specialty pharmacy patients.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Baxdrostat as First-in-Class Aldosterone Synthase Inhibitor for Hypertension
2
Insulin Deprescribing Utilizing Continuous Glucose Monitoring With Low-Dose Tirzepatide
3
FDA Approves Immgolis and Immgolis Intri as First Biosimilars to Golimumab Reference Products for RA and UC
4
FAQ: Guidance for Pharmacists, SSRIs Under Scrutiny and Political Debate
5



































































































































